Status:
COMPLETED
Vitamin D3 Levels in COVID-19 Outpatients From Western Mexico
Lead Sponsor:
University of Guadalajara
Conditions:
Covid19
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The immunomodulatory effects of vitamin D are known to be beneficial in viral infections, it is also known that its deficiency is associated with a worse prognosis of COVID-19. This study aimed to det...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Intervention group: Patients with positive PCR for COVID-19 of both sexes supplemented with vitamin D
- Control group: Patients with positive PCR for COVID-19 of both sexes
- Both groups: Mexican individuals, after signing the informed consent letter and over 18 years of age.
- Exclusion criteria:
- • Diseases that compromise the absorption of Vitamin D; Crohn's disease, cystic fibrosis, and celiac disease.
Exclusion
Key Trial Info
Start Date :
August 17 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 24 2020
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT04793243
Start Date
August 17 2020
End Date
October 24 2020
Last Update
March 11 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Universidad de Guadalajara
Guadalajara, Jalisco, Mexico, 44340